News from the healthcare data industry
Clinically validated MR brain perfusion images support earlier diagnosis, guidance of tumor biopsies, and post-surgical monitoring CAMBRIDGE, Mass., Nov. 16, 2022 /PRNewswire/ — The Eureka Clinical AI platform, from ConcertAI’s TeraRecon, now...
SAN FRANCISCO, Nov. 16, 2022 /PRNewswire/ — Verana Health®—a digital health company elevating quality in real-world data (RWD)—today announced it is developing Qdata™ MS, a Neurology Qdata module that will be used to help advance clinical research...
Global Industry leader to oversee RWE and Clinical Trials Technology Solutions CAMBRIDGE, Mass., Nov. 15, 2022 /PRNewswire/ — ConcertAI, a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life...
Innovative and interactive reporting functionality offers healthcare providers additional tools to complement integrated electronic health records and make it easier to review and act on results November 14, 2022 07:05...
CHICAGO, Nov. 14, 2022 /PRNewswire/ — EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, today named Sy Pretorius as the company’s new Chief Operating Officer and President, Outsourced...
MDClone’s synthetic data platform to streamline Jefferson’s path to knowledge generation and research publication PHILADELPHIA, Nov. 14, 2022 /PRNewswire/ — MDClone, a leading data analytics and synthetic data company, and Thomas Jefferson University and Jefferson Health today announced a...
Leading healthcare system will utilize venture capital firm’s network to drive artificial intelligence and digital health innovations in patient care (SACRAMENTO) UC Davis Health and General Catalyst have announced a new collaboration to...
Record-Breaking Gift Brings the PMC’s Total Contributions in Support of Cancer Research to $900 Million Since 1980 BOSTON, Nov. 14, 2022 /PRNewswire/ — Today, the Pan-Mass Challenge (PMC), the nation’s single most successful athletic fundraiser, announced...
Effort aligns MD Anderson’s drug development expertise with Exscientia’s AI-driven patient-first precision medicine and drug discovery platforms MD Anderson News Release November 14, 2022 The University of Texas MD Anderson Cancer Center...
It’s time to supercharge NCI’s role in redefining clinical trials and in strengthening the cancer research enterprise, NCI Director Monica Bertagnolli said Nov. 9 in her first director’s report. “I have...